SuperMush Raises $3 Million in Series A Funding
SuperMush, a company specializing in science-backed superfood supplements designed to enhance focus, energy, and recovery, has secured $3 million in a Series A funding round. The funding was led by NDude, a firm focused on healthcare and wellness investments.
Company Overview
Based in Beverly Hills, California, SuperMush was founded in 2022 by Alli Schaper and Brian Friedman. The company offers a range of products that utilize ingredients such as nootropics, adaptogens, and functional mushrooms, available in both retail and direct-to-consumer channels.
Use of Funds
The newly acquired capital will be directed towards expanding SuperMush's product line and further investing in high-efficacy formulations. The company also aims to strengthen its team and infrastructure to reach a broader customer base. SuperMush's products are currently sold in over 2,000 stores across the United States, including more than 1,000 Target and Sprouts locations, as well as online.
Leadership Comments
Alli Schaper, Co-Founder and CEO of SuperMush, expressed enthusiasm about the partnership with NDude, stating: "We are so excited to be partnering with NDude Labs for this next phase of our evolution." Vikram Sehgal, COO at NDude Labs, added that the investment will provide the necessary resources to accelerate SuperMush's growth sustainably.
Product Expansion
SuperMush has recently expanded its product offerings to include Shilajit, Creatine, and Lion's Mane gummies. The company plans to continue developing its product range with the new funds.
Conclusion
This funding round marks a significant step for SuperMush as it seeks to broaden its market presence and enhance its product lineup. With the support of NDude, SuperMush aims to build on its current momentum and continue delivering innovative wellness solutions.